BLTE
Belite Bio
$158.43
+$5.08 (+3.31%)Jul 27, 2026
Key metrics
The numbers that frame BLTE today
- Market cap
- $6.23B
- P/E (TTM)
- -80.3
- EV / FCF
- -158.2
- ROIC
- -29.1%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $60.00
- 52wk High
- $200.00
Growth
Revenue and earnings trend for BLTE
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BLTE
Is Belite Bio a good buy?
Hold. Belite Bio has excellent momentum, but poor quality makes the setup mixed. We think Belite Bio is selling at a high price.
What is the market capitalization of BLTE?
Belite Bio's market capitalization is $6.23B.
What is the P/E ratio for BLTE stock?
Belite Bio's current P/E ratio is -80.3.
What is the 52-week high for BLTE stock?
The 52-week high for Belite Bio is $200.00. The current close of $158.43 is 20.8% below that high.
What is the 52-week low for BLTE stock?
The 52-week low for Belite Bio is $60.00. The current close of $158.43 is 164.1% above that low.
Does BLTE stock pay dividends?
Belite Bio does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BLTE?
Belite Bio's Debt / Equity ratio is 0.